Objective: Early life stress (ELS) has been shown to influence health later in life. Functioning of the hypothalamic-pituitary-adrenal axis, regulated partly by FKBP5 gene, may moderate these effects. We examined whether FKBP5 single-nucleotide polymorphisms (SNPs) interact with ELS on Type 2 diabetes, cardiovascular disease, and quantitative glycemic traits. Methods: A total of 1728 Helsinki Birth Cohort Study participants born from 1934 to 1944 were genotyped for FKBP5 SNPs (rs1360780, rs9394309, rs9470080) and were administered a 2-hour (75 g) oral glucose tolerance test and a questionnaire on physician-diagnosed and medication use for chronic diseases at a mean age of 61.5 years. Of the participants, 273 had been exposed to ELS, operationalized as separation from their parents, at a mean age of 4.7 years due to evacuations during World War II. Results: ELS interacted with FKBP5 SNPs in the analyses of fasting (rs1360780, p = .015), 30-minute (rs1360780, p = .031; rs9394309, p = .041) and incremental insulin (rs1360780, p = .032; rs9394309, p = .028; rs9470080, p = .043), insulin area under the curve (rs1360780, p = .044), and impaired fasting glucose (rs9470080, p = .049); among carriers of at least one copy of minor allele, but not among major allele homozygotes, insulin values were higher, as were the odds for impaired fasting glucose if they had been separated compared with if they had not. Corresponding associations were found with a haplotype formed by minor alleles in all three SNPs for fasting, 30-minute, and incremental insulin (p < .05). Conclusions: FKBP5 polymorphisms in combination with ELS exposure predict higher insulin and glucose values in midlife. Our findings support the role for hypothalamic-pituitary-adrenal axis dysregulation in health-related metabolic outcomes.
INTRODUCTION
A dversities experienced early in life (early life stress; ELS), such as abuse, neglect, and separation from parents due to parental death, divorce, or war, have been shown to increase the risk for psychiatric disorders (1, 2) . Emerging data suggest that ELS is also associated with obesity and increased risk for cardiovascular diseases (CVDs) and Type 2 diabetes (T2D) (3) (4) (5) .
Although the mechanisms underlying these associations remain elusive, it has been suggested that ELS may exert its effects via functioning of the hypothalamic-pituitary-adrenal (HPA) axis. Although this pathway is biologically highly plausible (6) , empirical data supporting the association between plasma or serum cortisol levels, end products of HPA axis activity, with CVD, T2D, and glycemic traits have been inconsistent (7) (8) (9) . We are not aware of studies testing interactions between ELS and HPA axis hormonal products on CVD, T2D, and glycemic traits.
Apart from HPA axis hormonal products, focus on genes that participate in the HPA axis regulation may provide an alternate avenue to gain insight into the ELS pathway to disease. One key player participating in the HPA axis regulation is FKBP5 gene. FKBP5 codes for the FK506 binding protein 51, a heat shock protein 90 co-chaperone (10) . It participates in inhibition of the glucocorticoid receptor (GR) activity, which is the main regulator of the HPA axis activity (10) , whereas GR activation induces FKBP5 transcription via steroid hormone response elements (11) . Thus, FKBP5 forms an intracellular negative feedback loop that regulates the GR sensitivity and, simultaneously, is responsive to stressful exposures, making it a promising candidate for gene-environment (G Â E) interaction studies (12) .
The best investigated single-nucleotide polymorphisms (SNPs) belong to functional haplotype spanning the whole FKBP5 gene (from the promoter area to the 3′UTB in whites) that is tagged by rs3800373, rs9296158, or rs1360780 and contains up to 18 polymorphisms, which are in strong linkage disequilibrium (LD) with the tagging SNP (12) . Indeed, a series of studies have demonstrated that FKBP5 polymorphisms from this haplotype were associated with HPA axis reactivity: adults homozygous for minor alleles in rs1360780 (TT), rs3800373 (GG), and rs4713916 (AA) had elevated recovery plasma cortisol in response to Trier Social Stress Test (13) and infants who had one or two copies of minor T allele of rs1360780 had elevated salivary cortisol in response to Strange Situation Procedure (14) . Furthermore, adults who were exposed to ELS and had one or two copies of minor allele in rs1360780 (T), rs9296158 (A), rs9470080 (T), rs9394309 (G), or rs3800373 (C) had elevated risk of depression and subclinical symptoms (15) (16) (17) and posttraumatic stress disorder (PTSD) (2) .
However, we are aware of only one study that to date has examined whether FKBP5 SNPs interact with ELS on physical health outcomes: carriers of one or two minor T-alleles of rs1360780 were at increased risk for self-reported physician-diagnosed physical problems if they retrospectively reported exposure to physical, emotional, or sexual abuse in childhood, but not if they were homozygous major C-allele carriers (18) . However, the extent to which FKBP5 polymorphisms interact with ELS in predicting CVD, T2D, and quantitative glycemic traits remains unknown.
Accordingly, we examined if ELS, defined here as temporary separation from both biological parents due to child evacuations during World War II (WWII), interacted with three selected common FKBP5 SNPs (rs1360780, rs9394309, rs9470080) in predicting CVD, T2D, and quantitative glycemic traits in midlife.
METHODS

Participants
The Helsinki Birth Cohort Study (HBCS) includes 13345 white individuals who were born in Helsinki, Finland, between 1934 and 1944 and were alive living in Finland in 1971 when a unique personal identification number was allocated to each member of the Finnish population (19, 20 (19, 20) . Genotype data were available for 1728 participants (275 individuals were not included in the genetic analyses due to sex discrepancy, relatedness, failure in DNA sampling, or refusal to participate in the genotyping). Of them 273 were separated from their biological parents during WWII as indicated by the National Archives Registry or self-report in conjunction with the clinical examination, as described later.
In comparison to those not included in the analytic sample, those included were more often women (p < .001) and had lower levels of 30-minute glucose (p < .05) and fasting insulin (p < .001), but there were no differences in age, separation status, father's occupational status in childhood, CVD, T2D, or other insulin and glucose values. The study was carried out in accordance with the Declaration of Helsinki, and the study protocol was approved by the institutional review board of the National Public Health Institute. A written informed consent was obtained from all participants.
Diabetes, CVD, and Quantitative Glycemic Traits
In the morning after a 12-hour overnight fast, the participants were administered a 75-g oral glucose tolerance test (OGTT). During the OGTT, venous samples for plasma glucose and serum insulin were drawn at 0, 30, and 120 minutes. Plasma glucose was measured with a glucose dehydrogenase method (HemoCue, Ängelholm, Sweden) and serum insulin with a fluoroimmunoassay (Delphia; PerkinElmer Finland, Turku, Finland). During the same visit, the participants filled in a questionnaire where they provided information about physician-diagnosed chronic diseases and use of medication for these diseases.
The participants were defined as having diabetes if they reported a physician-diagnosed diabetes or use of antidiabetic medication or if they met the World Health Organization (21) criteria for diabetes based on the OGTT (fasting plasma glucose ≥7.0 mM or 2-hour plasma glucose ≥11.1 mM), CVD if they reported physician-diagnosed coronary heart disease and/or stroke, and impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) if they met the World Health Organization criteria (21) (IFG: fasting plasma glucose 6.1-6.9 mM and 2-hour plasma glucose <7.8 mM; IGT: fasting plasma glucose <7.0 mM and 2-hour plasma glucose ≥7. 8 
Early Life Stress
Using the Finnish National Archives' registry (25), we identified 215 (12.4%; 54.4% women) participants in this study cohort who were separated temporarily from their parents in childhood. The mean age at separation was 4.7 years (0.6-10.1 years) and the mean length of separation was 1.7 years (0.2-4.7 years). Data on age at and length of separation were available on a subset of 198 and 194 participants, respectively. The separations took place during WWII when nearly 80,000 Finnish children were evacuated from the strains of war to Sweden or Denmark without their biological parents (25) .
In addition, some children were evacuated without their parents either abroad or within homeland through personal contacts of the families: it has been estimated that this group may include more than 20,000 children (25) . A question addressing wartime separation from both parents was embedded in the survey at age 61.5 years when the participants attended the clinical examination. An additional 58 (3.4%; 53.4% women) participants self-reported as having been separated from both parents during WWII. Because of constraints that relate to memorizing events occurring at earliest stages in life and because events rather than sequences of timing of the same events are recalled more accurately (26), we did not use self-reported information on age at and length of separation.
Genotyping and SNP Selection
Genotypes of intronal SNPs rs1360780, rs9394309, and rs9470080 were taken from the modified Illumina 610k array. These SNPs were selected using three criteria: their location in FKBP5 gene within functional haplotype (12); previously frequently reported significant G Â E associations with risk of depression (15) (16) (17) and PTSD (2) in adulthood after ELS, and altered HPA axis reactivity (13, 14) ; and minor allele frequency > 5% in this sample (see later). Genotyping was conducted at the Wellcome Trust Sanger Institute, Cambridge, UK, according to standard protocols. Genotyping success rate was greater than 99 % in all three SNPs analyzed in this study. Observed genotype frequencies did not deviate from the Hardy-Weinberg equilibrium (p > .39). Minor allele frequencies were 21.6 % (C > T), 24.3 % (A > G), and 25.6 % (C > T) for rs1360780, rs9394309, and rs9470080, respectively. SNPs were in high LD in this sample (r 2 = 0.72-0.94) and, according to the solid spine algorithm with default values, belonged to the same haploblock (Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/PSYMED/A351).
Covariates and Confounders
Covariates included age at the time of clinical examination (years) and sex, father's occupational status in childhood derived from child welfare clinic and school health care records and categorized into three groups (lower, middle, upper), own maximum attained level of education in adulthood (basic/primary or less, lower secondary, upper secondary, or tertiary) recorded at 5-year intervals during the period 1970-2005 by Statistics Finland, body mass index (BMI; in kg/m 2 ) as calculated from measured weight (kg) and height (m), depressive symptoms (27, 28) measured with the Beck Depression Inventory (27) , and stressful life events the past 12 months measured using the Stressful Life Event Scale (28), and to control for population stratification, the first three multidimensional scaling components were derived from multidimensional scaling analyses performed with Plink. In addition to using reported physician-diagnosed diabetes and antidiabetic medication use as part of the T2D diagnosis outcome, we used them as covariates in the analyses of glycemic traits.
Statistical Analyses
Multiple linear regression analysis examined if the three selected polymorphisms in FKBP5 gene, separation status, and their interaction were associated with the continuous outcomes (fasting, 30-minute, 2-hour, and AUC insulin and glucose; incremental insulin; ISI; and HOMA IR ) and logistic regression analysis examined these associations with the binary outcomes (IFG, IGT, T2D, and CVD). Each SNP was tested in a separate model assuming both additive and dominant genetic effects. We further performed haplotype analysis, where rs1360780, rs9394309, and rs9470080 were analyzed within one haploblock in one model. In addition, we tested whether length of (median split at 1.4 years; dummy coded with nonseparated group as referent) and age at (median split at 3.9 years; dummy coded with nonseparated group as referent) separation interacted with the three selected SNPs in predicting the continuous and binary outcomes. These analyses were not conducted with haplotype because of the smaller sample size.
All continuous variables were log-transformed to attain normality. All analyses were adjusted for covariates as described in the Results section. We also made adjustments for SNP by covariate and separation status by covariate interactions (29) .
The level of significance was set to α = .05. At this α level, post hoc study power, computed using the observed power option in the multivariate general linear model test, varied from 0.050 to 0.64. The SNPs were in high LD and belonged to one haploblock (Fig. S1 , Supplemental Digital Content 1, http://links.lww.com/PSYMED/A351), whereas the outcomes were highly correlated between each other (r 2 = 0.66-0.93 and r 2 = −0.45 to 0.99 for glucose-and insulin-related outcomes, respectively). Principal component analysis revealed two factors, with eigenvalue > 1 explaining 82.2% of the total variance. Therefore, to correct for multiple testing, we also present Bonferroni corrected p values assuming two multiple tests.
IBM SPSS 24, Plink, and R 3.2.2 software were used for the analyses. Linkage disequilibrium between the SNPs and haploblock structure was evaluated with Haploview 4.2 (30) . Analyses of haplotypes were performed with the Haplo.stats package 1.6.11 of the R statistical software (31) .
RESULTS
Characteristics of the sample according to the separation status are presented in Table 1 . As we have reported previously (3), men and women were equally likely to have been separated from their parents, and in comparison to those who were not separated, those who were separated were slightly older at the time of testing in adulthood, but there were no significant differences in father's occupational status in childhood or BMI in adulthood between the groups (Table 1) . In accordance to Alastalo et al. (3) that used a slightly larger sample (n = 2003) from which our genotyped sample (n = 1728) was derived, the number of individuals with CVDs (p = .001) and with IGT (p = .045) was significantly higher and the number of individuals with T2D trended to be higher (p = .069) in the separated than in the nonseparated group. However, in contrast to Pesonen et al. (1), who used a slightly smaller (n = 1681) than our genotyped sample and included father's military service or death in the frontier into the separation group and excluded it from the nonseparated group, those separated did not differ from those not separated in depressive symptoms (p = .42). Because our definition of separation differed from that of Pesonen et al. (1), we also ran analyses testing if the FKBP5 SNPS interacted with father's military service or death on CVD, T2DM, or glycemic traits, and found no significant interactions (p values > .06).
FKBP5 Polymorphisms by ELS
In the unadjusted models and in the models adjusted for covariates, rs1360780 interacted significantly with separation status in the analyses of fasting, 30-minute, incremental, and AUC insulin (Fig. 1) , rs9394309 interacted significantly with separation status in the analyses of 30-minute and incremental insulin (Fig. 2) , and rs9470080 interacted significantly with separation status in the analysis of incremental insulin (Fig. 3) . Table 2 shows that across all the significant interactions, insulin values were higher among carriers of at least one copy of the minor allele if they were separated in comparison to if they were not; no differences between separated and nonseparated groups existed among homozygous major allele carriers (for the analyses in Table 2 , we combined carriers of one and two copies of minor alleles because the group of individuals homozygous for minor alleles in each of the SNPs in the separated group was small, n = 12-13). We re-ran the FKBP5 by ELS interaction analyses using dominant genetic model by contrasting those who were carriers of one or two minor alleles against homozygous major allele carriers and all the significant interactions that we found when using the additive genetic model remained (p values for interactions = .019-.036, Bonferronicorrected p values = .038-.072). In these analyses, however, we also found an additional significant interaction between rs9470080 and separation status with IFG (p value for interaction = .049; Bonferroni-corrected p value = .098): among carriers of at least one copy of minor allele, the odds for IFG was higher in the separated (n = 87 [20.3%] ) in comparison to the nonseparated group (n = 535 [13.4%]; odds ratio = 1.84, 95% confidence interval = 0.97 -3.52, p = .06); no such difference was found in homozygous major allele carriers (odds ratio = 0.68, 95% confidence interval = 0.37-1.25, p = .21).
All the significant interactions remained unaffected when we made further adjustments for own maximum adulthood education (p values for interactions = .014-.037, Bonferroni-corrected p values = .028-.074); similarly, the results remained virtually identical when we added depressive symptoms and stressful life events into the regression models, except in the analyses of IFG, the interactions became slightly attenuated (p = .062 and .050, Bonferroni-corrected p = .12 and .098, respectively). When additionally adjusted for antidiabetic medication and physiciandiagnosed diabetes, the only interaction that remained significant was that of rs1360780 by separation status on fasting insulin (p = .009, Bonferroni-corrected p = .018). Also, a previously nonsignificant interaction between rs1360780 by separation status on HOMA-IR became significant (p = .030, Bonferroni-corrected p = .059). This interaction, in alignment with the others, showed that HOMA-IR values were higher among carriers of at least one copy of the minor allele if they were separated in comparison to if they were not, whereas no differences between separated and nonseparated groups existed among homozygous major allele carriers (data not shown).
Haplotype analysis demonstrated that carriers of the haplotype formed by the minor alleles in rs1360780, rs9394309, and rs9470080 (19.6% of individuals) who were separated from their parents showed higher levels of fasting (p values for interaction = .048, Bonferroni-corrected p = .096), 30-minute (p values for interaction = .032, Bonferroni-corrected p = .064), and incremental insulin (p values for interaction = .021, Bonferronicorrected p = .042), thus, confirming our findings from the single SNPs by separation status analyses. None of the covariate adjustments affected these findings, except when adjusting for antidiabetic medication use and physician-diagnosed diabetes, only the results for fasting insulin remained unaffected (p = .021). In addition, minor allele carriers of this haplotype showed higher levels of HOMA-IR (p = .049).
The findings remained virtually identical when we made adjustments for the SNP by covariate and separation status by covariate interactions into the models (data not shown). in those who were (separated) and who were not (not separated) exposed to early life stress. Error bars reflect standard error (SE) of mean. Values are adjusted for sex, age, and body mass index at the time of clinical examination; father's occupational status in childhood; and the first three multidimensional scaling components derived from multidimensional scaling analyses performed with Plink. A p value < .025 is significant at Bonferroni-corrected level p < .05. at median of 3.9 years or younger in comparison to if they were not separated (p values < .043); no such differences existed among homozygous major allele carriers (p values > .091; data not shown). We did not pursue testing these interactions on CVD, T2D, IFG, or IGT because of small cell sizes in minor allele carriers.
FKBP5 Polymorphisms by Length of and Age at ELS
DISCUSSION
Our study demonstrates that three selected FKBP5 polymorphisms moderate the association of ELS on insulin and glucose values at fasting state and/or during an OGTT in midlife. These polymorphisms, rs1360780, rs9394309, and rs9470080, are in high LD, belong to one haploblock (12) , and have been previously linked with risk of depression (15) (16) (17) and PTSD (2) in adulthood after ELS; rs1360780 has also been associated with HPA axis activity in adults and infants (13, 14) . In our study among carriers of at least one copy of the minor allele, those who had been exposed to ELS had higher insulin values at fasting and 30 minutes after the glucose load, higher incremental and the AUC insulin, and higher odds for IFG, compared with carriers not exposed to ELS. No such differences in these glycemic traits were found in carriers homozygous for the major allele. These findings were further confirmed by the haplotype analyses in which a haplotype formed by these three SNPs interacted with ELS in predicting the quantitative glycemic traits: carriers of the haplotype formed by the minor alleles had higher levels of fasting, 30-minute, and incremental insulin if they were separated in comparison to those who were not. These findings were not explained by sex of the participant, age, BMI, depressive symptoms, stressful life events measured at the testing in midlife, father's occupational status in childhood, own maximum attained education in adulthood, multidimensional scaling components controlling for population stratification, or their interactions with the SNPs and ELS (29) . However, when we made adjustments for antidiabetic medication use and physician-diagnosed diabetes, only the ELS by rs1360780 and ELS by haplotype interactions on fasting insulin remained significant; although in these analyses also, these two interactions became significant on insulin resistance. Our findings, thus, suggest that ELS is associated with higher insulin and glucose values in midlife if we do not take into account their antidiabetic medication use and T2D diagnosis, and with higher insulin and insulin resistance values when we do, in individuals genetically vulnerable to HPA axis dysregulation.
We did not, however, find G Â E interactions in the analyses of T2D or CVD. Instead, the risks of CVD and IGT were significantly higher and T2D trended to be higher for individuals exposed to ELS (3) regardless of their genetic vulnerability to HPA axis dysregulation by the FKBP5. This may suggest that the three selected FKBP5 polymorphisms, although related to HPA axis reactivity, offer a perspective that grasps only a surface of the FIGURE 2. Estimated marginal means for 30-minute insulin in response to oral glucose tolerance test (A) and incremental insulin (B) for different genotypes of the FKBP5 single-nucleotide polymorphism rs93694309 in those who were (separated) and who were not (not separated) exposed to early life stress. Error bars reflect standard error (SE) of mean. Values are adjusted for sex, age, and body mass index at the time of clinical examination; father's occupational status in childhood; and the first three multidimensional scaling components derived from multidimensional scaling analyses performed with Plink. A p value < .025 is significant at Bonferroni-corrected level p < .05. FIGURE 3. Estimated marginal means for incremental insulin for different genotypes of the FKBP5 single-nucleotide polymorphism rs9470080 in those who were (separated) and who were not (not separated) exposed to early life stress. Error bars reflect standard error (SE) of mean. Values are adjusted for sex, age, and body mass index at the time of clinical examination; father's occupational status in childhood; and the first three multidimensional scaling components derived from multidimensional scaling analyses performed with Plink. A p value < .025 is significant at Bonferronicorrected level p < .05.
pathways that may explain the ELS-manifest disease associations. Indeed, both diabetes and CVD are complex polygenic agingrelated disorders. Future G Â E studies using the genome-wide approach (32) in much larger samples than ours may unravel the presumably complex genetic pathways via which ELS may exert effects on manifest T2D and CVD. Such studies will, however, need to concur challenges that relate not only to the sample size but also to ELS exposures that are quantitatively and qualitatively comparable across individuals.
Because we did, however, find significant G Â E interactions on higher levels of quantitative glycemic traits, which predict increased risk of future T2D and CVD (21), we cannot rule out that another explanation for the lack of significant G Â E interactions on T2D and CVD relates to the still relatively young age of the sample and, consequently, small number of individuals with manifest disease decreasing statistical power to detect significant associations. Future follow-up studies of this cohort will tell if the increased risk in the genetically vulnerable individuals exposed to ELS will translate into manifest disease as the participants of our cohort age.
Furthermore, elevated concentrations of insulin, which we observed in the participants with minor alleles in rs1360780, rs9394309, and rs9470080 and a haplotype formed from these alleles who also experienced ELS, may be an indication of compensatory hyperinsulinemia-increased insulin secretion in β cells in an attempt to overcome insulin resistance (6) . However, if not controlled, after a period of compensatory hyperinsulinemia with normal glucose tolerance, β-cell insulin secretion declines, insulin receptors get down-regulated, and IGT and eventually overt T2D may result (33) . Therefore, follow-up studies of HBCS participants are essential to see if this transition occurs, particularly in those who carry the environmental and genetic risks.
Two potential pathways may account for these findings. First, chronic or repeated exposure to stress (or a single exposure to severe stress) and associated elevated levels of stress hormones can lead to increased portal and peripheral free fatty acids, impaired ability of insulin to translocate intracellular SLC2A4 glucose transporters to the cell surface, and insulin hypersecretion (34, 35) . These effects lead to long-term metabolic consequences, which include hypertension, metabolic syndrome, insulin resistance, and T2D (35) . When stress is experienced in the early stages of development, it may lead to attenuated development of the hippocampus and amygdala, areas that have a high density of GRs and persistent postnatal neurogenesis (36) and that are implicated in T2D (34, 35) . Childhood trauma may also exert its effect via affecting DNA methylation and, subsequently, the function of genes later in life (37) . A recent study supports this interpretation because patterns of DNA demethylation for the FKBP5 rs1360780 SNP in the whole blood were linked to early childhood adversity (38) . Thus, in combination with preexisting genetic vulnerability, chronic alterations in the activity of the stress system early in life may have permanent effects on brain development and endocrine and metabolic systems (35, 36) .
Alternatively, presence of risk alleles in FKBP5 gene in combination with ELS may disrupt mammalian target of rapamycin (mTOR) signaling pathway, which integrates signals from nutrients, growth factors (including insulin), and information on energy status to regulate many processes in the organism (39, 40) . mTOR is an atypical serine/threonine protein kinase that interacts with Mean differences were log-transformed to attain normality and are presented in percentage differences between values in the individuals who were separated from parents versus those who were not. The results are presented from the models adjusted for sex, age, and BMI at the time of clinical examination; father's occupational status in childhood; and the first three multidimensional scaling components derived from multidimensional scaling analyses performed with Plink. ELS = early life stress; SNP = single-nucleotide polymorphism; AUC = area under the curve; 95% CI = confidence interval. a n = 951-1067.
b n = 649-760.
several proteins to form two distinct complexes-mTOR complexes 1 (mTORC1) and 2 (mTORC2) (39) . Animal studies indicate that the glucose uptake, insulin sensitivity, and animal growth in vivo are dependent on both mTOR complexes (41) . Heightened mTORC2 signals were associated with insulin resistance due to mTORC2-mediated degradation of insulin receptor substrate-1 (42). Importantly, both mTORC1 and mTORC2 are partly regulated by FKBP family proteins (43, 44) . In turn, elevated glucocorticoids in the hippocampus, which are associated with ELS exposure (36) , were demonstrated to have direct effect on mTOR signaling pathway in mice, with significant reduction in hippocampal mTOR protein in the animals with a history of stress (40) . Because FKBP5 is associated with both mTOR regulation (44) and GR activity (12), G Â E interaction in this region on metabolic outcomes is plausible. Strengths of our study relate to the longitudinal study design, relatively large sample size, objectively recorded ELS augmented by self-report, and clinical measurement of glucose tolerance. Moreover, we were able to take into account several potential covariates. Nevertheless, some limitations should be addressed. First, the experience of early childhood separation may have varied from negative to positive. This remains an unavoidable study limitation because we do not have data on the ELS experience, and any adulthood recall of events in childhood is at least to some extent biased. Furthermore, staying in Finland during the war with one's parent(s) may have been equally or even more stressful than the separation from one's parent(s). However, both the separated and the nonseparated participants were exposed to war in childhood, because none of the children were evacuated before the war broke out, and some of the separated children returned home during the war. Hence, our findings may offer a rather conservative estimate of the differences between the separated and the nonseparated groups. We cannot rule out that an explanation for a lack of significant G Â E interactions for some of our outcomes lies in the sample size. Therefore, although we also found significant G Â E interactions on fasting insulin and/or HOMA-IR when we specified the ELS exposure further by length of and age at separation, these associations should be interpreted with caution. Although post hoc power calculations are generally not recommended, because they always demonstrate low power (<50%) with respect to a nonsignificant or nominally significant associations (45, 46) , our findings encourage future studies to test these interaction associations in larger samples. Finally, when we made corrections for multiple testing, only interactions with fasting and/or incremental insulin remained. Also, this finding encourages further studies with larger samples sizes.
To conclude, our study shows that the association between ELS and quantitative glycemic traits was dependent on the three selected FKBP5 SNPs (rs1360780, rs9394309, and rs9470080) and their haplotype. ELS predicted higher values in those with minor alleles in any or all of these SNPs, whereas ELS was not associated with insulin or glucose levels in those homozygous for major allele. Our findings support the role for HPA axis dysregulation in health-related metabolic outcomes. 
